“Two-phase”的搜索结果，显示 121-130 项，共有 4783 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by Phase 3), parallel-arm study of avelumab in ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The study will be performed in two phases: Phase I will be performed for biologic validation of marker candidates from a discovery cohort and phase II ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... phase 2 dose (RP2D) and preferred schedule, and assess preliminary anti ... A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by Phase 3), parallel-arm study of avelumab in ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... Phase 2 dose (RP2D) for \[177Lu\]Lu FAP 2286 monotherapy in participants with FAP expressing solid tumors. Phase 2 is designed to evaluate the safety and ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This is a Phase 2 global, multi-center, open-label study to assess the ... In the phase II part, to evaluate the preliminary antitumor activity of two ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... Phase 2 dose (RP2D) for \[177Lu\]Lu FAP 2286 monotherapy in participants with FAP expressing solid tumors. Phase 2 is designed to evaluate the safety and ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... phase 2 dose (RP2D) and preferred schedule, and assess preliminary anti ... A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Participants in both Phase 1 and 2 will be selected for treatment with \[177Lu\]Lu FAP 2286 based on \[68Ga\]Ga FAP 2286 imaging for determining tumor FAP ...

10. 放射科- 临床试验- 妙佑医疗国际

    ... 2 or 3 meningioma as measured by 6-month PFS rate. ... ADPKD is a leading cause of end-stage renal disease. ... 2 or 3 meningioma as measured by 6-month PFS rate.